(FDA) An agency of the US federal government established by Congress in 1912 and presently part of the US Department of Health and Human Services. The FDA gives classifications of medical devices according to potential risks and controls the safety of marketed drugs.

See also Class I II III Devices, Phase 1 2 3 4 Drug Trials and Legal Requirements.

GE Healthcare is the result of the merger between GE Medical and Amersham Health in Nov. 2004, after GE acquired Amersham Health for 9.5 billion in Oct. 2003. Jeffrey R. Immelt, Chairman of the Board and Chief Executive of General Electric, said, 'Amersham's diagnostic pharmaceutical and life sciences business will add new, high growth platforms to GE Medical's diagnostic imaging, services and healthcare information technology businesses'. GE Healthcare, a UK company, is a unit of General Electric (NYSE: GE). GE Healthcare is a global leader in medical imaging, diagnostic imaging contrast agents, interventional procedures, healthcare services, and information technology. For more than 100 years, health care providers have relied on GE Medical Systems, now GE Healthcare, for high quality medical technology and productivity solutions. GE Healthcare, headquartered now at formerly seat of Amersham Health in Great Britain, operates facilities around the world. Global Operations include organizations on the Americas, Europe, and Asia, including India, Japan, Korea China, Thailand and Vietnam.

MRI Scanners:

0.2T to 1.0T:
to 1.5T:
to 3.0T:

MRI Contrast Agents:

The France-based Guerbet Group is highly specialized in contrast media for medical imaging. Its strategic goal is to be a key player in this market. Products include Dotarem (Magnetic Resonance Imaging) and Xenetix (X-ray Imaging).

MRI Contrast Agents:

IMRIS® is a Canadian manufacturer of Magnetic Resonance Imaging Systems for use in neurosurgical operating rooms. The 1.5T intra-operative system, developed by IMRIS, is the only system of its kind in the world. This patented, intra-operative system, is designed so that the magnet moves over the patient for imaging (before, during and after surgery), and then is retracted to allow complete surgical access to the patient.

MRI Scanners:

1.5T:

ISOL Technology participated in the pioneering the Korea's MRI development since the early 1980's. In spite of the rapidly changing business environment, and severe competition in the overall medical market, ISOL Technology has grown steadily each year and has established itself as a major provider of Magnetic Resonance(MR) Imaging Systems in Korea.
ISOL Technology also has the largest market share of the domestic bone densitometry equipment sales and is currently in the early stages of development of the 61 channel MCG (Magnetocardiography) system with the R and D funds from the Korean Ministry of Commerce, Industry and Energy.

MRI Scanners:

0.35T to 0.5T:
1.5T:
3T: